Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates
National Institutes of Health (NIH) sent this bulletin at 08/12/2019 10:30 AM EDTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
08/12/2019 10:00 AM EDT
The study is part of the emergency response to an ongoing Ebola outbreak in the North Kivu and Ituri Provinces.
Update Your E-mail Address | Add Subscriptions | Unsubscribe
If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website.
This service is provided to you by the National Institutes of Health.
NIH…Turning Discovery Into Health®
 |